Genomic Health Continues International Push, Invests in Two Startups amid Double-Digit Q1 Revenue Growth
May 04, 2011
Genomic Health Continues International Push, Invests in Two Startups amid Double-Digit Q1 Revenue Growth
The company plans to take advantage of the double-digit growth rates it is seeing in the US market "to fund higher levels of investment in our international business, where market development activities are focused on physician education and payor reimbursement programs."
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Genomic Health's InVitae Merged with Locus Development to Create Independent Clinical Genomics Firm
August 15, 2012 / Clinical Sequencing News - Genomic Health Partners with OncoMed on NGS-based Biomarker Discovery; Plans New Hires for InVitae
May 9, 2012 / Clinical Sequencing News - Genomic Health's New Subsidiary Will Apply Next-Gen Sequencing to Rare and Common Genetic Diseases
February 8, 2012 / Clinical Sequencing News - Genomic Health to Present Results of RNA-seq Biomarker Study at San Antonio Breast Cancer Symposium
November 2, 2011 / Clinical Sequencing News - Genomic Health Completes Transcriptome Sequencing Study, Files Patents for NGS Library Prep
August 9, 2011 / Clinical Sequencing News